Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Ezetemibe
Ezetimibe
163222-33-1
|
409.425
|
3.958
Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. The primary target of ezetimibe is the cholesterol transport protein Niemann-Pick C1-Like 1 (NPC1L1) protein. Ezetimibe is indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor.
EZE | Ezetimibe | Ezetrol | SCH58235 | Zetia | ezetemibe | ezetimib
Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. The primary target of ezetimibe is the cholesterol transport protein Niemann-Pick C1-Like 1 (NPC1L1) protein. Ezetimibe is indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor.
EZE | Ezetimibe | Ezetrol | SCH58235 | Zetia | ezetemibe | ezetimib
$19/5 mg
(EBC)
1
We provide 0 compound for Ezetemibe